Ethier C R, Chan D W
Department of Mechanical and Industrial Engineering, 5 King's College Road, University of Toronto, Toronto, Ontario M5S 3G8, Canada.
Invest Ophthalmol Vis Sci. 2001 Jul;42(8):1795-802.
To determine the effect of charged moieties within the outflow pathway on aqueous outflow facility in human eyes.
After baseline facility measurement in human eye bank eyes (n = 10 pairs), one eye of each pair received anterior chamber exchange and continued perfusion with medium containing 10 mg/ml cationic ferritin. Contralateral eyes were treated in a similar manner with anionic ferritin (10.0 or 102 mg/ml). Eyes were fixed by anterior chamber exchange and perfusion with universal fixative at 8 mm Hg (corresponding to a physiologic pressure of 15 mm Hg in vivo) and examined by transmission electron microscopy. In a second series of human eyes (n = 8 pairs), facility was measured before and after anterior chamber exchange, with a solution containing 0.1 U/ml neuraminidase.
Perfusion of eyes with anionic ferritin at either 10.0 or 102 mg/ml caused a negligible 2% increase in facility, whereas cationic ferritin perfusion reduced facility by 66% (P < 0.00001). Perfusion with fixative reduced facility by approximately 60% in both cationic and anionic ferritin-perfused eyes, relative to facilities after perfusion with ferritin. Transmission electron microscopy showed that the distribution of ferritin was segmentally variable. Cationic ferritin consistently labeled the luminal surface of the inner wall of Schlemm's canal, and variably labeled the juxtacanalicular connective tissue (JCT) and trabecular beam surfaces. Anionic ferritin was more prominent in the JCT and intertrabecular spaces and less so on the luminal surface of Schlemm's canal. By scanning electron microscopy, cationic ferritin was seen to accumulate at intercellular margins of the inner wall. Neuraminidase perfusion had no significant effect on outflow facility.
Cationic ferritin reduces outflow facility, presumably by binding to negatively charged sites in the outflow pathway. A possible mechanism is partial or complete blockage of intercellular clefts in the inner wall of Schlemm's canal by the ferritin that accumulates on the luminal surface of the inner wall. Although they are possible targets for ferritin binding, sialyl residues themselves seem to have little direct effect on outflow facility. Our data indicate that positively charged molecules, especially if they can interact with inner wall pores, have the potential to markedly alter outflow facility.
确定房水流出途径中的带电部分对人眼房水流出易度的影响。
在人眼库眼球(n = 10对)进行基线易度测量后,每对眼球中的一只接受前房置换,并用含10 mg/ml阳离子铁蛋白的培养基持续灌注。对侧眼球用阴离子铁蛋白(10.0或102 mg/ml)以类似方式处理。通过前房置换并在8 mmHg(相当于体内15 mmHg的生理压力)下用通用固定剂灌注来固定眼球,然后用透射电子显微镜检查。在另一组人眼(n = 8对)中,在进行前房置换前后,用含0.1 U/ml神经氨酸酶的溶液测量易度。
用10.0或102 mg/ml的阴离子铁蛋白灌注眼球,易度增加可忽略不计,仅为2%,而阳离子铁蛋白灌注使易度降低了66%(P < 0.00001)。相对于用铁蛋白灌注后的易度,用固定剂灌注使阳离子和阴离子铁蛋白灌注的眼球的易度均降低了约60%。透射电子显微镜显示铁蛋白的分布呈节段性变化。阳离子铁蛋白始终标记施莱姆管内壁的腔面,并可变地标记近管周结缔组织(JCT)和小梁表面。阴离子铁蛋白在JCT和小梁间隙中更突出,在施莱姆管腔面上则较少。通过扫描电子显微镜观察,可见阳离子铁蛋白在内壁的细胞间边缘积聚。神经氨酸酶灌注对流出易度无显著影响。
阳离子铁蛋白降低流出易度,推测是通过与流出途径中的带负电位点结合。一种可能的机制是积聚在内壁腔面的铁蛋白部分或完全阻塞施莱姆管内壁的细胞间裂隙。尽管唾液酸残基可能是铁蛋白结合的靶点,但它们本身似乎对流出易度几乎没有直接影响。我们的数据表明,带正电的分子,特别是如果它们能与内壁孔隙相互作用,有可能显著改变流出易度。